Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Joy Ho

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Clinical and Laboratory Haematology|October 3, 2002
Chromosomal and genetic abnormalities in myelomaP Joy Ho
Methods in Molecular Medicine|June 22, 2005
Identification of malignant plasma cells by mRNA in situ hybridizationRoss D Brown, P Joy Ho
Internal Medicine Journal|February 24, 2025
A new era in myeloma: the advent of chimeric antigen receptor-T (CAR-T) cells and bispecific antibodiesP Joy Ho, Eric W Li
Clinical Lymphoma & Myeloma|October 16, 2008
Regulatory T cells and multiple myelomaDouglas E Joshua, Ross D Brown, P Joy Ho, et al.
Reviews in Clinical and Experimental Hematology|March 6, 2003
The biology and cytogenetics of multiple myelomaP Joy Ho, Lynda J Campbell, John Gibson, et al.
Internal Medicine Journal|April 10, 2020
Successful kidney transplantation in a patient with stable multiple myelomaChristina Lai, Tracey Ying, P Joy Ho, et al.
Internal Medicine Journal|July 14, 2023
Pregnancy and assisted reproductive technology use in Australian female transfusion-dependent haemoglobinopathy patients: a 20-year retrospective analysisStephanie Anderson, Jacinta Perram, Anna Nelson, et al.
Leukemia & Lymphoma|April 23, 2004
B7+ T cells in myeloma: an acquired marker of prior chronic antigen presentationRoss Brown, Allan Murray, Belinda Pope, et al.
Current Cancer Drug Targets|July 20, 2006
The use of thalidomide in myeloma therapy as an effective anticancer drugDaniel M-Y Sze, Ross Brown, Shihong Yang, et al.
Oncoimmunology|December 25, 2012
Trogocytosis generates acquired regulatory T cells adding further complexity to the dysfunctional immune response in multiple myelomaRoss Brown, Hayley Suen, James Favaloro, et al.
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Clinical and Laboratory Haematology|October 3, 2002
Chromosomal and genetic abnormalities in myelomaP Joy Ho
Methods in Molecular Medicine|June 22, 2005
Identification of malignant plasma cells by mRNA in situ hybridizationRoss D Brown, P Joy Ho
Internal Medicine Journal|February 24, 2025
A new era in myeloma: the advent of chimeric antigen receptor-T (CAR-T) cells and bispecific antibodiesP Joy Ho, Eric W Li
Clinical Lymphoma & Myeloma|October 16, 2008
Regulatory T cells and multiple myelomaDouglas E Joshua, Ross D Brown, P Joy Ho, et al.
Reviews in Clinical and Experimental Hematology|March 6, 2003
The biology and cytogenetics of multiple myelomaP Joy Ho, Lynda J Campbell, John Gibson, et al.
Internal Medicine Journal|April 10, 2020
Successful kidney transplantation in a patient with stable multiple myelomaChristina Lai, Tracey Ying, P Joy Ho, et al.
Internal Medicine Journal|July 14, 2023
Pregnancy and assisted reproductive technology use in Australian female transfusion-dependent haemoglobinopathy patients: a 20-year retrospective analysisStephanie Anderson, Jacinta Perram, Anna Nelson, et al.
Leukemia & Lymphoma|April 23, 2004
B7+ T cells in myeloma: an acquired marker of prior chronic antigen presentationRoss Brown, Allan Murray, Belinda Pope, et al.
Current Cancer Drug Targets|July 20, 2006
The use of thalidomide in myeloma therapy as an effective anticancer drugDaniel M-Y Sze, Ross Brown, Shihong Yang, et al.
Oncoimmunology|December 25, 2012
Trogocytosis generates acquired regulatory T cells adding further complexity to the dysfunctional immune response in multiple myelomaRoss Brown, Hayley Suen, James Favaloro, et al.
Pageof 9